PT - JOURNAL ARTICLE AU - Deng, Qi TI - Dynamics and Prediction of the COVID-19 Epidemics in the US – a Compartmental Model with Deep Learning Enhancement AID - 10.1101/2020.05.31.20118414 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.31.20118414 4099 - http://medrxiv.org/content/early/2020/06/03/2020.05.31.20118414.short 4100 - http://medrxiv.org/content/early/2020/06/03/2020.05.31.20118414.full AB - Compartmental models dominate epidemic modeling. Estimations of transmission parameters between compartments are typically done through stochastic parameterization processes that depend upon detailed statistics on transmission characteristics, which are economically and resource-wide expensive to collect. We apply deep learning techniques as a lower data dependency alternative to estimate transmission parameters of a customized compartmental model, for the purposes of projecting further development of the US COVID-19 epidemics. The deep learning-enhanced compartment model predicts that the basic reproduction rate (R0) will become less than one around June 18–19, 2020, and that the US “Infected” population will peak on June 17–18, 2020 at around 1·36 million individual cases. The model also predicts that the number of accumulative confirmed cases will cross the 2 million mark around June 11, 2020. It also projects that the infection transmission parameter will drop to virtually zero as early as July 8, 2020, implying that the total number of confirmed cases will likely become stabilized around that time frame (predicted at 2·23–2·24 million).Competing Interest StatementThe authors have declared no competing interest.Funding StatementNAAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesUp-to-date time series data available up request.